|
Form Serial Number: |
DA20201204E00324
|
1.
Date of relevant event: |
25/11/2020 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
01/12/2020 (dd/mm/yyyy)
|
3.
Stock code: |
06855 |
4.
Name of listed corporation: |
Ascentage Pharma Group International - B |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
224,299,727 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Tian |
(Other names) |
Yuan |
|
|
|
10.
Name of director (Chinese): |
田源 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1710 | Miscellaneous Voluntary disclosure (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
|
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 20,724,676 | 9.25 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 20,724,676 | 9.23 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2020 | 15/08/2028 | | | HKD | 0.010 | | | 73,178 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2021 | 15/08/2028 | | | HKD | 0.010 | | | 73,178 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2022 | 15/08/2028 | | | HKD | 0.010 | | | 73,179 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2023 | 15/08/2028 | | | HKD | 0.010 | | | 73,179 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Shenzhen Qianhai Yuanming Asset Management Co., Ltd. | Qianhai Complex A201, Qianwan Road 1, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen,P.R.China | Tian Yuan | 90.00 | N | |
Shenzhen Qianhai Yuanming Healthcare Fund (Limited Partnership) | Qianhai Complex A201, Qianwan Road 1, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen,P.R.China | Shenzhen Qianhai Yuanming Asset Management Co., Ltd. | 100.00 | N | |
QHYM Investment Ltd | Vistra Corporate Services Centre Wickhams Cay II Road Town Tortola VG1110 British Virgin Islands | Shenzhen Qianhai Yuanming Healthcare Fund (Limited Partnership) | 100.00 | Y | |
Zhuhai Hengqin Yuanming Asset Management Co., Ltd | 1576 Room 105, No.6 Baohua Road, Hengqin New District, Zhuhai, China | Tian Yuan | 50.00 | N | |
Zhuhai Hengqin Yuanming Private Equity (Limited Partnership) | 1859 Room 105, No.6 Baohua Road, Hengqin New District, Zhuhai, China | Zhuhai Hengqin Yuanming Asset Management Co., Ltd | 100.00 | N | |
YM Investment Ltd | Offshore Incorporations (Cayman) Limited Floor 4, Willow House Cricket Square P O Box 2804 Grand Cayman KY1-1112 Caymand Islands | Zhuhai Hengqin Yuanming Private Equity (Limited Partnership) | 100.00 | Y | |
Yuanming Capital Group Limited | Sertus Incorporations (BVI) Limited, Sertus Chambers, P.O. BOX 905, Quastisky Building, Road Twon, Tortola, British Virgin Islands | Tian Yuan | 100.00 | N | |
Yuanming Capital Management Limited | Sertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite #5-204, 23 Lime Tree Bay Avenue, P.O. BOX 2547, Grand Cayman, KY1-1104, Cayman Islands | Yuanming Capital Group Limited | 50.00 | N | |
Yuanming Prudence SPC | Office of Sertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite# 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KYl-1104, Cayman Islands | Yuanming Capital Management Limited | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Tian Yuan holds his interest in box 28 through pre-IPO share options. The number of the issued shares of the Company was increased from 223,901,727 to 224,299,727 due to issuance of an aggregate of 398,000 shares upon exercise of share options. For details, please refer to the next day disclosure return of the Company dated 25 November 2020.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
04/12/2020 (dd/mm/yyyy)
|
|